Stromal cell-derived factor (SDF)-1␣ is involved in the trafficking of hematopoietic stem cells from bone marrow to peripheral blood, and its expression is increased in the penumbra of the ischemic brain. In this study, SDF-1␣ was found to exert neuroprotective effects that rescued primary cortical cultures from H 2 O 2 neurotoxicity, and to modulate neurotrophic factor expression. Rats receiving intracerebral administration of SDF-1␣ showed less cerebral infarction due to up-regulation of antiapoptotic proteins, and they had improved motor performance. SDF-1␣ injection enhanced the targeting of bone marrow (BM)-derived cells to the injured brain, as demonstrated in green fluorescent protein-chimeric mice with cerebral ischemia. In addition, increased vascular density in the ischemic cortex of SDF-1␣-treated rats enhanced functional local cerebral blood flow. In summary, intracerebral administration of SDF-1␣ resulted in neuroprotection against neurotoxic insult, and it induced increased BM-derived cell targeting to the ischemic brain, thereby reducing the volume of cerebral infarction and improving neural plasticity.Stroke is a major cause of mortality worldwide (van Gijn and Dennis, 1998), and bone marrow stem cell transplantation has been demonstrated to be a potential strategy for its treatment (Li et al., 2002). Under ischemic conditions, circulating stem cells seem to selectively migrate to ischemic regions to support the plasticity and functional recovery of damaged tissue (Orlic et al., 2001). However, the signals that guide stem cells to ischemic lesions are as yet unknown. Stromal cell-derived factor (SDF)-1␣, a CXC chemokine produced by bone marrow stromal cells, is a potent chemoattractant for hematopoietic stem cells (HSCs), and it is constitutively expressed by all tissues (Shirozu et al., 1995). Recent reports have indicated that SDF-1␣ is a strong chemoattractant for CD34 ϩ cells, which express CXCR4, the receptor for SDF-1␣, and play an important role in HSC trafficking between peripheral circulation and bone marrow (Petit et al., 2002). Studies of mice lacking SDF-1␣ or CXCR4 have confirmed that SDF-1␣ is necessary for the migration of HSCs from fetal liver to bone marrow (Zou et al., 1998). In addition, the expression of SDF-1␣ in the brains of human immunodeficiency virus (HIV)-positive patients suggests that SDF-1␣ may play a role in neuroprotection in response to HIV infection (Langford et al., 2002). Therefore, SDF-1␣/CXCR4 signaling may also play an important neuroprotective/neuroplastic role in the repair of neural tissue injury.Expression of CXCR4 and SDF-1␣ after focal cerebral ischemia (Stumm et al., 2002) led us to speculate that this chemokine may also signal adhesion and migration of HSCs to ischemic tissue. On this basis, we hypothesized that locally This work was supported in part by Chen-Han Foundation for Education, Academia Sinica Grant 94M003 and National Science Council Grant NSC95-2745-B-001-001-MY3.Article, publication date, and citation information can be found at...